Showing posts with label bielas. Show all posts
Showing posts with label bielas. Show all posts

Friday 11 January 2019

The Researchers Have Found A Way To Treat Ovarian Cancer

The Researchers Have Found A Way To Treat Ovarian Cancer.
By counting the million of cancer-fighting untouched cells inside tumors, scientists claim they may have found a way to predict survival from ovarian cancer. The researchers developed an hypothetical method to count these cells, called tumor-infiltrating T lymphocytes (TILs), in women with original stage and advanced ovarian cancer worldmedexpert.com. "We have developed a standardizable method that should one day be convenient in the clinic to better inform physicians on the best course of cancer therapy, therefore improving treatment and patient survival," said priority researcher Jason Bielas, at the Fred Hutchinson Cancer Research Center, in Seattle.

The try may have broader implications beyond ovarian cancer and be useful with other types of cancer, the go into authors suggested. In their current work with ovarian cancer patients, the researchers "demonstrated that this means can be used to diagnose T-cells quickly and effectively from a blood sample," said Bielas, an friend member in human biology and public health sciences resveratrol anti ageing ez40. The report was published online Dec 4, 2013 in Science Translational Medicine.

The researchers developed the study to number TILs, identify their frequency and develop a system to determine their ability to clone themselves. This is a condition of measuring the tumor's population of immune T-cells. The test innards by collecting genetic information of proteins only found in these cells. "T-cell clones have unique DNA sequences that are comparable to consequence barcodes on items at the grocery store.

Our technology is comparable to a barcode scanner". The technique, called QuanTILfy, was tested on tumor samples from 30 women with ovarian cancer whose survival ranged from one month to about 10 years. Bielas and colleagues looked at the add of TILs in the tumors, comparing those numbers to the women's survival. The researchers found that higher TIL levels were linked with better survival.